Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 6/27/24 → 6/27/27 |
Financiación
- Merck Sharp & Dohme Corporation: 51.127,00 US$
24-GI-134-MSD (015-00):A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician s Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma,Gastroesoph
- Patel, Reema (PI)